• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Nathbiogen Share Price

    Nath Bio-Genes (India) Share PriceNath Bio-Genes (India)

    Small Cap 3.1k Result
    ₹205.95
    -1.8 (-0.87%)
    As on 27 September, 2023 | 16:32 BSE: 537291 NSE: NATHBIOGENISIN: INE448G01010

    Nath Bio-Genes (India) Performance

    Day Range

    • Low 205
    • High 210
    205.95

    52 Week Range

    • Low 128.85
    • High 244.6
    205.95
    • Open Price205.65
    • Previous Close207.75
    • Volume32697

    Start SIP in Nath Bio-Genes (India)

    Start SIP

    Nath Bio-Genes (India) Share Price

    • Over 1 Month -2.97%
    • Over 3 Month 9.32%
    • Over 6 Month 45.81%
    • Over 1 Year 29.24%

    Nath Bio-Genes (India) Key Statistics

    P/E Ratio 10.4
    PEG Ratio 0.1
    Market Cap Cr 391
    Price to Book Ratio 0.7
    EPS 18.5
    Dividend 1
    Relative Strength Index 44.37
    Money Flow Index 64.41
    MACD Signal -0.29
    Average True Range 9

    Nath Bio-Genes (India) Investment Rating

    • Master Rating:

    • Nath Bio Genes India has an operating revenue of Rs. 952.71 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 12% is healthy, ROE of 6% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 16% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 69 which is a FAIR score but needs to improve its earnings, a RS Rating of 62 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 134 indicates it belongs to a poor industry group of Agricultural Operations and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock definitely has some strength, you may want to examine it in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Nath Bio-Genes (India) Financials
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 23545252220927
    Operating Expenses Qtr Cr 19841201717548
    Operating Profit Qtr Cr 3746534-21
    Depreciation Qtr Cr 111111
    Interest Qtr Cr 323332
    Tax Qtr Cr 001003
    Net Profit Qtr Cr 3321131-116
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 302280
    Operating Expenses Annual Cr 252241
    Operating Profit Annual in Cr 4937
    Depreciation Cr 33
    Interest Annual Cr 1011
    Tax Annual Cr 14
    Net Profit Annual Cr 35-67
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 3817
    Cash from Investing Activity Annual Cr -3-20
    Cash from Financing Annual Activity Cr -2-22
    Net Cash Flow Annual Cr 34-25
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 573542
    Fixed Assets Annual Cr 244245
    Total Non Current Assets Annual Cr 272272
    Total Current Assets Annual Cr 521470
    Total Assets Annual Cr 793742
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 302285
    ROE Annual % 6-12
    ROCE Annual % 87
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1614
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 235
    Operating Expenses Qtr Cr 198
    Operating Profit Qtr Cr 37
    Depreciation Qtr Cr 1
    Interest Qtr Cr 3
    Tax Qtr Cr 0
    Net Profit Qtr Cr 33
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 302280
    Operating Expenses Annual Cr 253241
    Operating Profit Annual in Cr 4937
    Depreciation Cr 33
    Interest Annual Cr 1011
    Tax Annual Cr 14
    Net Profit Annual Cr 35-67
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 3817
    Cash from Investing Activity Annual Cr -3-20
    Cash from Financing Annual Activity Cr -2-22
    Net Cash Flow Annual Cr 34-25
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 573542
    Fixed Assets Annual Cr 244245
    Total Non Current Assets Annual Cr 272272
    Total Current Assets Annual Cr 521468
    Total Assets Annual Cr 793739
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 302285
    ROE Annual % 6-12
    ROCE Annual % 87
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1614

    Nath Bio-Genes (India) Technicals

    EMA & SMA

    Current Price
    ₹205.95
    -1.8 (-0.87%)
    • Bullish Moving Average
    • ___
    • 5
    • Bearish Moving Average
    • ___
    • 11
    • 20 Day
    • ₹213.39
    • 50 Day
    • ₹211.23
    • 100 Day
    • ₹201.09
    • 200 Day
    • ₹191.45
    • 20 Day
    • ₹213.97
    • 50 Day
    • ₹215.97
    • 100 Day
    • ₹199.59
    • 200 Day
    • ₹177.59

    Nath Bio-Genes (India) Resistance and Support

    PIVOT
    ₹207.97
    Resistance
    First Resistance ₹210.89
    Second Resistance ₹214.02
    Third Resistance ₹216.94
    RSI 44.37
    MFI 64.41
    MACD Single Line -0.28
    MACD -1.6
    Support
    First Resistance ₹204.84
    Second Resistance ₹201.92
    Third Resistance ₹198.79

    Nath Bio-Genes (India) Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 42,566 2,562,048 60.19
    Week 59,014 3,187,925 54.02
    1 Month 103,370 5,661,583 54.77
    6 Month 77,517 4,087,489 52.73

    Nath Bio-Genes (India) Result Highlights

    Nath Bio-Genes (India) Synopsis

    NSE-Agricultural Operations

    Nath Bio-Genes is involved in the business activities of Growing of non-perennial crops. Company’s Total Operating Revenue is Rs. 301.29 Cr. and Equity Capital is Rs. 19.00 Cr. for the Year ended 31/03/2023. Nath Bio-Genes (India) Ltd. is a Public Limited Listed company incorporated on 14/07/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L01110MH1993PLC072842 and registration number is 072842.
    Market Cap 390
    Sales 327
    Shares in Float 1.03
    No of funds 12
    Yield 0.96
    Book Value 0.69
    U/D Vol ratio 1.4
    LTDebt / Equity
    Alpha 0.07
    Beta 0.97

    Nath Bio-Genes (India)

    Owner NameJun-23Mar-23Dec-22Sep-22
    Promoters 45.6%45.6%45.6%45.6%
    Mutual Funds 4.62%4.62%4.62%4.62%
    Foreign Portfolio Investors 0.07%0.13%0.15%0.01%
    Financial Institutions/ Banks
    Individual Investors 30.37%30.17%30.62%31.61%
    Others 19.34%19.48%19.01%18.16%

    Nath Bio-Genes (India) Management

    Name Designation
    Mr. Satish Kagliwal Managing Director
    Mr. Madhukar Deshpande Director
    Ms. Ashu Jain Director
    Mrs. Jeevanlata Kagliwal Director
    Mr. Vadla Nagabhushanam Director
    Mrs. Sweta Kagliwal Director
    Mr. Hitesh Purohit Director

    Nath Bio-Genes (India) Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Nath Bio-Genes (India) Corporate Action

    Date Purpose Remarks
    2023-08-10 Quarterly Results
    2023-04-22 Audited Results & Final Dividend
    2023-02-14 Quarterly Results
    2022-10-20 Quarterly Results
    2022-08-13 Quarterly Results

    Nath Bio-Genes (India) MF Shareholding

    Name Amount(cr)
    Aditya Birla Sun Life Pure Value Fund Growth 4697
    • Company Name
    • CMP
    • Chg(%)
    • Company Name
    • CMP
    • Chg(%)

    Nath Bio-Genes (India) FAQs

    What is Share Price of Nath Bio-Genes (India) ?

    Nath Bio-Genes (India) share price is ₹205 As on 27 September, 2023 | 16:18

    What is the Market Cap of Nath Bio-Genes (India) ?

    The Market Cap of Nath Bio-Genes (India) is ₹391.4 Cr As on 27 September, 2023 | 16:18

    What is the P/E ratio of Nath Bio-Genes (India) ?

    The P/E ratio of Nath Bio-Genes (India) is 10.4 As on 27 September, 2023 | 16:18

    What is the PB ratio of Nath Bio-Genes (India) ?

    The PB ratio of Nath Bio-Genes (India) is 0.7 As on 27 September, 2023 | 16:18

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.